108 related articles for article (PubMed ID: 6226460)
1. Inhibition of 3-beta-hydroxy steroid dehydrogenase activity in first trimester human pregnancy with trilostane and WIN 32729.
van der Spuy ZM; Jones DL; Wright CS; Piura B; Paintin DB; James VH; Jacobs HS
Clin Endocrinol (Oxf); 1983 Oct; 19(4):521-31. PubMed ID: 6226460
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of progesterone secretion with trilostane for mid-trimester termination of pregnancy: randomized controlled trials.
le Roux PA; Tregoning SK; Zinn PM; van der Spuy ZM
Hum Reprod; 2002 Jun; 17(6):1483-9. PubMed ID: 12042266
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of ovarian, placental, and adrenal steroidogenesis in the rhesus monkey by trilostane.
Schane HP; Potts GO; Creange JE
Fertil Steril; 1979 Oct; 32(4):464-7. PubMed ID: 114429
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in first- and second-trimester human pregnancy and the luteal phase using Epostane.
Pattison NS; Webster MA; Phipps SL; Anderson AB; Gillmer MD
Fertil Steril; 1984 Dec; 42(6):875-81. PubMed ID: 6437877
[TBL] [Abstract][Full Text] [Related]
5. Steroidogenesis inhibitors. 1. Adrenal inhibitory and interceptive activity of trilostane and related compounds.
Christiansen RG; Neumann HC; Salvador UJ; Bell MR; Schane HP; Creange JE; Potts GO; Anzalone AJ
J Med Chem; 1984 Jul; 27(7):928-31. PubMed ID: 6330362
[TBL] [Abstract][Full Text] [Related]
6. Effects of Epostane on progesterone synthesis in early human pregnancy.
Birgerson L; Odlind V; Johansson ED
Contraception; 1986 Apr; 33(4):401-10. PubMed ID: 3731777
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of trilostane on the progestin milieu in the pregnant mare.
Schutzer WE; Kerby JL; Holtan DW
J Reprod Fertil; 1996 Jul; 107(2):241-8. PubMed ID: 8882291
[TBL] [Abstract][Full Text] [Related]
8. Induction of abortion in early first trimester human pregnancy using epostane.
Webster MA; Gillmer MD
Br J Obstet Gynaecol; 1989 Mar; 96(3):340-5. PubMed ID: 2713292
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human placental progesterone synthesis and aromatase activity by synthetic steroidogenic inhibitors in vitro.
Rabe T; Kiesel L; Kellermann J; Weidenhammer K; Runnebaum B; Potts GO
Fertil Steril; 1983 Jun; 39(6):829-35. PubMed ID: 6574022
[TBL] [Abstract][Full Text] [Related]
10. Acute administration of a 3 beta-hydroxysteroid dehydrogenase inhibitor to rhesus monkeys at the midluteal phase of the menstrual cycle: evidence for possible autocrine regulation of the primate corpus luteum by progesterone.
Duffy DM; Hess DL; Stouffer RL
J Clin Endocrinol Metab; 1994 Dec; 79(6):1587-94. PubMed ID: 7989460
[TBL] [Abstract][Full Text] [Related]
11. Cortisol, aldosterone, cortisol precursor, androgen and endogenous ACTH concentrations in dogs with pituitary-dependant hyperadrenocorticism treated with trilostane.
Sieber-Ruckstuhl NS; Boretti FS; Wenger M; Maser-Gluth C; Reusch CE
Domest Anim Endocrinol; 2006 Jul; 31(1):63-75. PubMed ID: 16233969
[TBL] [Abstract][Full Text] [Related]
12. Effects of hydroxysteroid dehydrogenase inhibitors on in-vitro and in-vivo steroidogenesis in the ovine adrenal gland.
Singh-Asa P; Jenkin G; Thorburn GD
J Endocrinol; 1982 Feb; 92(2):205-12. PubMed ID: 6278042
[TBL] [Abstract][Full Text] [Related]
13. Effect of progesterone withdrawal in sheep during late pregnancy.
Taylor MJ; Webb R; Mitchell MD; Robinson JS
J Endocrinol; 1982 Jan; 92(1):85-93. PubMed ID: 7057124
[TBL] [Abstract][Full Text] [Related]
14. Trilostane but not prostaglandin F2alpha (PGF2alpha) or cortisol aborts 90-day-pregnant lutectomized sheep.
Weems YS; Vincent DL; Lemme C; Weems CW
Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):77-86. PubMed ID: 10560611
[TBL] [Abstract][Full Text] [Related]
15. The influence of trilostane on steroid hormone metabolism in canine adrenal glands and corpora lutea-an in vitro study.
Ouschan C; Lepschy M; Zeugswetter F; Möstl E
Vet Res Commun; 2012 Mar; 36(1):35-40. PubMed ID: 22113849
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Cushing's syndrome with trilostane (WIN 24,540), an inhibitor of adrenal steroid biosynthesis.
Komanicky P; Spark RF; Melby JC
J Clin Endocrinol Metab; 1978 Nov; 47(5):1042-51. PubMed ID: 233687
[TBL] [Abstract][Full Text] [Related]
17. 11 beta-Hydroxy-11-ketosteroids equilibrium, a source of misinterpretation in steroid synthesis: evidence through the effects of trilostane on 11 beta-hydroxysteroid dehydrogenase in sheep and human adrenals in vitro.
Touitou Y; Auzeby A; Bogdan A; Luton JP; Galan P
J Steroid Biochem; 1984 Mar; 20(3):763-8. PubMed ID: 6231429
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of trilostane and cyanoketone on the 3 beta-hydroxysteroid dehydrogenase-isomerase reactions in androgen and 16-androstene biosynthetic pathways in the pig testis.
Cooke GM
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):95-101. PubMed ID: 8809191
[TBL] [Abstract][Full Text] [Related]
19. Antiprogestins.
Crooij MS
Eur J Obstet Gynecol Reprod Biol; 1988 Jun; 28(2):129-32. PubMed ID: 3042493
[TBL] [Abstract][Full Text] [Related]
20. The 3beta-hydroxysteroid dehydrogenase inhibitor trilostane shows antidepressant properties in mice.
Espallergues J; Givalois L; Temsamani J; Laruelle C; Maurice T
Psychoneuroendocrinology; 2009 Jun; 34(5):644-59. PubMed ID: 19117688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]